MedTrace Logo

Plans4Care: Personalized Dementia Care on Demand

NCT07115251 · Status: NOT_YET_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2025-08-11

No results posted yet for this study

Summary

The Plans4Care study is a research study funded by the National Institute on Aging (Grant# R44AG084365). The Plans4Care app is designed to help family caregivers address over 90 common care challenges such as behavioral symptoms (anxiety, agitation), functional changes and other concerns, and receive an action plan which provides easy-to-use non-drug strategies, resources, tips and education.

The goal of the study is to evaluate whether using the Plans4Care app will help you feel more confident providing care to your family member with dementia, better understand dementia, and enhance your own well-being. You also have the option to talk with a care advisor who can practice use of strategies or address concerns you may have.

Conditions

  • Dementia
  • Dementia Alzheimer Type
  • Alzheimer Dementia (AD)
  • Memory Loss

Interventions

BEHAVIORAL

Plans4Care

Caregivers assigned to treatment condition will receive: 1) access to the web-app; 2) an orientation to the web-app involving initial set up; and 3) a brief video explaining use of the web-app. Caregivers will be guided through accessing the platform, creating an account and completing a brief set of background questions.

Sponsors & Collaborators

  • Drexel University

    collaborator OTHER

  • Thomas Jefferson University

    collaborator OTHER

  • National Institute on Aging (NIA)

    collaborator NIH

  • Plans4Care Inc

    lead INDUSTRY

Principal Investigators

  • Sokha Koeuth, DHSc · Plans4Care Inc

  • Eric Jutkowitz, PhD · Plans4Care Inc

  • Laura N. Gitlin, PhD, FGSA,FAAN · Drexel University

  • Catherine V Piersol, PhD, OTR/L,FAOTA, FNAP · Thomas Jefferson University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-30
Primary Completion
2027-08-30
Completion
2027-09-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07115251 on ClinicalTrials.gov